Responses to diuretic treatment in gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1

Kidney and Blood Pressure Research

Volumn 32, Issue 2, 2009, Pages 119-127

  Artunc, Ferruh ^a   Ebrahim, Ammar ^a   Siraskar, Balasaheb ^a   Nasir, Omaima ^a   Rexhepaj, Rexhep ^a   Amann, Kerstin ^b   Friedrich, Bjoern ^a   Risler, Teut ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aldosterone; NaCl cotransporter; Renal outer medullary K+ channel; Signal transduction; Transporters

Indexed keywords

ALDOSTERONE; CANRENOIC ACID; EPITHELIAL SODIUM CHANNEL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; MESSENGER RNA; POLO LIKE KINASE 2; POTASSIUM; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TRIAMTERENE; UREA;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURETIC THERAPY; DRUG MECHANISM; DRUG POTENCY; FLUID INTAKE; FOOD INTAKE; GENE LOSS; GENE TARGETING; IMMUNOFLUORESCENCE; KIDNEY; KNOCKOUT GENE; MOUSE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM ABSORPTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UREA BLOOD LEVEL; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; DIURETICS; DRUG TOLERANCE; EATING; EPITHELIAL SODIUM CHANNEL; GENE TARGETING; IMMEDIATE-EARLY PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; TRIAMTERENE;

EID: 65449147110     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214439     Document Type: Article

References (39)

1. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL: Characterization of sgk, a novel member of the serine/threonine protein ki- nase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 1993;13:2031-2040.
2. Bhargava A, Fullerton MJ, Myles K, Purdy TM, Funder JW, Pearce D, Cole TJ: The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology 2001; 142:1587-1594.
3. Loffing J, Zecevic M, Feraille E, Kaissling B, Asher C, Rossier BC, Firestone GL, Pearce D, Verrey F: Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: possible role of SGK. Am J Physiol Renal Physiol 2001;280:F675- F682.
4. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D: Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 1999;96:2514-2519.
5. Naray-Fejes-Toth A, Canessa C, Cleaveland ES, Aldrich G, Fejes-Toth G: sgk is an aldo- sterone-induced kinase in the renal collecting duct: effects on epithelial Na+ channels. J Biol Chem 1999;274:16973-16978.
6. Shigaev A, Asher C, Latter H, Garty H, Re- uveny E: Regulation of sgk by aldosterone and its effects on the epithelial Na(+) channel. Am J Physiol Renal Physiol 2000; 278:F613-F619.
7. Boehmer C, Palmada M, Klaus F, Jeyaraj S, Lindner R, Laufer J, Daniel H, Lang F: The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2. Cell Physiol Biochem 2008; 22: 705-714.
8. Boehmer C, Laufer J, Jeyaraj S, Klaus F, Lindner R, Lang F, Palmada M: Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination. Cell Physiol Bio- chem 2008;22: 591-600.
9. Jeyaraj S, Boehmer C, Lang F, Palmada M: Role of SGK1 kinase in regulating glucose transport via glucose transporter GLUT4. Biochem Biophys Res Commun 2007; 356: 629-635.
10. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V: (Patho)physio- logical significance of the serum- and gluco- corticoid-inducible kinase isoforms. Physiol Rev 2006; 86:1151-1178.
11. Rajamanickam J, Palmada M, Lang F, Boehmer C: EAAT4 phosphorylation at the SGK1 consensus site is required for transport modulation by the kinase. J Neurochem 2007;102: 858-866.
12. Sato JD, Chapline MC, Thibodeau R, Frizzell RA, Stanton BA: Regulation of human cystic fibrosis transmembrane conductance regulator (CFTR) by serum- and glucocorticoid- inducible kinase (SGK1). Cell Physiol Bio-chem 2007; 20: 91-98.
13. Shaw JR, Sato JD, VanderHeide J, LaCasse T, Stanton CR, Lankowski A, Stanton SE, Chap- line C, Coutermarsh B, Barnaby R, Karlson K, Stanton BA: The role of SGK and CFTR in acute adaptation to seawater in Fundulus heteroclitus. Cell Physiol Biochem 2008;22:69-78.
14. Strutz-Seebohm N, Shojaiefard M, Christie D, Tavare J, Seebohm G, Lang F: PIKfyve in the SGK1 mediated regulation of the cre- atine transporter SLC6A8. Cell Physiol Bio-chem 2007; 20:729-734.
15. Yun CC, Palmada M, Embark HM, Fedoren- ko O, Feng Y, Henke G, Setiawan I, Boehmer C, Weinman EJ, Sandrasagra S, Korbmacher C, Cohen P, Pearce D, Lang F: The serum and glucocorticoid-inducible kinase SGK1 and the Na+/H+ exchange regulating factor NHERF2 synergize to stimulate the renal outer medullary K+ channel ROMK1. J AmSoc Nephrol 2002; 13: 2823-2830.
16. Wang D, Zhang H, Lang F, Yun CC: Acute activation of NHE3 by dexamethasone correlates with activation of SGK1 and requires a functional glucocorticoid receptor. Am J Physiol Cell Physiol 2007; 292:C396-C404.
17. Yun CC, Chen Y, Lang F: Glucocorticoid activation of Na(+)/H(+) exchanger isoform 3 revisited. The roles of SGK1 and NHERF2. J Biol Chem 2002; 277: 7676-7683.
18. Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Broer S: Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA 2000;97:8157-8162.
19. Setiawan I, Henke G, Feng Y, Bohmer C, Vasilets LA, Schwarz W, Lang F: Stimulation of Xenopus oocyte Na(+),K(+)ATPase by the serum and glucocorticoid-dependent kinase sgk1. Pflügers Arch 2002;444:426-431.
20. Zecevic M, Heitzmann D, Camargo SM, Verrey F: SGK1 increases Na,K-ATP cell-surface expression and function in Xenopus laevis oocytes. Pflugers Arch 2004; 448:29-35.
21. Fejes-Toth G, Frindt G, Naray-Fejes-Toth A, Palmer LG: Epithelial Na+ channel activation and processing in mice lacking SGK1. Am J Physiol Renal Physiol 2008;294:F1298-F1305.
22. Wulff P, Vallon V, Huang DY, Volkl H, Yu F, Richter K, Jansen M, Schlunz M, Klingel K, Loffing J, Kauselmann G, Bosl MR, Lang F, Kuhl D: Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest 2002;110: 1263-1268.
23. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, Boucher R, Rossier BC: Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet 1996; 12: 325-328.
24. Hummler E, Barker P, Talbot C, Wang Q, Verdumo C, Grubb B, Gatzy J, Burnier M, Horisberger JD, Beermann F, Boucher R, Rossier BC: A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proc Natl Acad Sci USA 1997;94:11710-11715.
25. McDonald FJ, Yang B, Hrstka RF, Drummond HA, Tarr DE, McCray PB Jr, Stokes JB, Welsh MJ, Williamson RA: Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci USA 1999; 96: 1727-1731.
26. Barker PM, Nguyen MS, Gatzy JT, Grubb B, Norman H, Hummler E, Rossier B, Boucher RC, Koller B: Role of gammaENaC subunit in lung liquid clearance and electrolyte balance in newborn mice: insights into perinatal adaptation and pseudohypoaldosteronism. J Clin Invest 1998; 102: 1634-1640.
27. Berger S, Bleich M, Schmid W, Cole TJ, Peters J, Watanabe H, Kriz W, Warth R, Greger R, Schutz G: Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc Natl Acad Sci USA 1998; 95: 9424-9429.
28. Kim GH: Long-term adaptation of renal ion transporters to chronic diuretic treatment. Am J Nephrol 2004; 24: 595-605.
29. + transporter abundances in response to chronic thiazide or loop diuretic treatment in rats. Am J Physiol Renal Physiol 2003;284: F133-F143.
30. Lant A: Diuretics: clinical pharmacology and therapeutic use. Part II. Drugs 1985;29: 162-188.
31. Lant A: Diuretics: clinical pharmacology and therapeutic use. Part I. Drugs 1985;29: 57-87.
32. Huber SM, Friedrich B, Klingel K, Lenka N, Hescheler J, Lang F: Protein and mRNA expression of serum and glucocorticoid-dependent kinase 1 in metanephrogenesis. Dev Dyn 2001;221:464-469.
33. Artunc F, Sandulache D, Nasir O, Boini KM, Friedrich B, Beier N, Dicks E, Potzsch S, Klingel K, Amann K, Blazer-Yost BL, Scholz W, Risler T, Kuhl D, Lang F: Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone. Pflügers Arch 2008; 456: 425-436.
34. Rexhepaj R, Artunc F, Grahammer F, Nasir O, Sandu C, Friedrich B, Kuhl D, Lang F: SGK1 is not required for regulation of colonic ENaC activity. Pflügers Arch 2006;453: 97-105.
35. Huang DY, Boini KM, Friedrich B, Metzger M, Just L, Osswald H, Wulff P, Kuhl D, Val- lon V, Lang F: Blunted hypertensive effect of combined fructose and high-salt diet in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1. Am J Physiol Regul Integr Comp Physiol 2006; 290:R935-R944.
36. Huang DY, Boini KM, Osswald H, Friedrich B, Artunc F, Ullrich S, Rajamanickam J, Palmada M, Wulff P, Kuhl D, Vallon V, Lang F: Resistance of mice lacking the serum- and glucocorticoid-inducible kinase SGK1 against salt-sensitive hypertension induced by a high-fat diet. Am J Physiol Renal Physi- ol 2006;291:F1264-F1273.
37. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD: Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med 2005; 11: 861-866.
38. + elimination in the sgk1-knockout mouse. J Am Soc Nephrol 2004;15:885-891.
39. Boini KM, Graf D, Kuhl D, Haussinger D, Lang F: SGK1 dependence of insulin induced hypokalemia. Pflügers Arch 2008; 457: 955-961